MoonLake Immunotherapeutics (NASDAQ: MLTX)
Entity

  • MoonLake Immunotherapeutics (NASDAQ: MLTX)

    Created in 2021


  • Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    6,260

  • Activities

    deeptech biotech

  • Entity types

    Startup

  • Location

    Dorfstrasse 29, 6300 Zug, Switzerland

    Zug

    Switzerland

  • Employees

    Scale: 11-50

    Estimated: 115

  • Engaged catalyst

    3
    0 0

  • Added in Motherbase

    1 year, 10 months ago
Description
  • Value proposition

    Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science

    MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

    Immunotherapy, inflammatory skin & joint diseases, partnering, IL17A / F, #MLTX, #Nanobody, #HS, #PsA, and #IL17

Catalyst interactions
Catalyst TypeTweets Articles
HSBC
HSBC
Bank, Financial Services
HSBC
Bank, Financial Services 		Other

1 Jul 2024


Sofinnova Partners
Sofinnova Partners
Financial Services
Sofinnova Partners
Financial Services 		Other

19 Nov 2022


Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services 		Other

14 Apr 2025


Social network dynamics
Last news
Show all articles